In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Alpelisib, approved in combination with fulvestrant in 2019 for the treatment of···【more】
Release date:2024-08-22Recommended:471
Anamorelin is a ghrelin receptor agonist used to treat cancer cachexia and signi···【more】
Release date:2024-08-22Recommended:393
Anamorelin is currently the only effective therapeutic drug that promotes appeti···【more】
Release date:2024-08-22Recommended:425
Koselugois a precision small molecule MEK blocker engineered for specific tumors···【more】
Release date:2024-08-22Recommended:440
Anamorelin is a ghrelin receptor agonist launched in Japan that brings a new tre···【more】
Release date:2024-08-22Recommended:453
Koselugois a precision small molecule MEK inhibitor designed for specific tumor ···【more】
Release date:2024-08-22Recommended:513
Koselugo is a carefully developed small molecule MEK blocker (also known as a mi···【more】
Release date:2024-08-22Recommended:503
As the world's first drug specifically for the treatment of cachexia, Anamor···【more】
Release date:2024-08-22Recommended:438
Anamorelin is a drug that mimics the function of ghrelin in the human body, whic···【more】
Release date:2024-08-22Recommended:449
Koselugo is a carefully developed small molecule MEK inhibitor (also known as a ···【more】
Release date:2024-08-22Recommended:410
Koselugo is a class of finely designed small molecule MEK blockers (also known a···【more】
Release date:2024-08-22Recommended:417
Koselugo is a precisely targeted small molecule MEK inhibitor with a therapeutic···【more】
Release date:2024-08-22Recommended:419